Press Release

GBT Announces Participation at the Leerink Partners 7th Annual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it will present at the Leerink Partners 7th Annual Global Healthcare Conference in New York City on Wednesday, February 14, 2018 at 9:00 a.m. Eastern Time.

The presentation will be webcast live and available for replay from GBT’s website at www.gbt.com in the Investors section.

About Global Blood Therapeutics
GBT is a clinical-stage biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing its lead product candidate, voxelotor, as an oral, once-daily therapy for sickle cell disease. To learn more, please visit www.gbt.com and follow the company on Twitter @GBT_news.

Contact Information:
Myesha Lacy (investors)
GBT
650-351-4730
investor@globalbloodtx.com

Julie Normart (media)
W2O pure
415-946-1087
media@globalbloodtx.com

                                                                                                                                                                    

Primary Logo

Global Blood Therapeutics, Inc.